NASDAQ:GILD   Gilead Sciences, Inc.
2
GILD has suffered over the past 3 quarters, but with a reshaping of its business, we could see them pushing up into positive territory again. Looking for a TL break and the momentum to continue.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。